Medicenna Therapeutics Corp (MDNA) - Total Liabilities

Latest as of December 2025: CA$6.85 Million CAD ≈ $4.96 Million USD

Based on the latest financial reports, Medicenna Therapeutics Corp (MDNA) has total liabilities worth CA$6.85 Million CAD (≈ $4.96 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Medicenna Therapeutics Corp - Total Liabilities Trend (2014–2025)

This chart illustrates how Medicenna Therapeutics Corp's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Medicenna Therapeutics Corp's working capital to evaluate short-term liquidity relative to the company's equity base.

Medicenna Therapeutics Corp Competitors by Total Liabilities

The table below lists competitors of Medicenna Therapeutics Corp ranked by their total liabilities.

Company	Country	Total Liabilities
Murray International Trust LSE:MYI	UK	GBX112.39 Million
Derwent London PLC LSE:DLN	UK	GBX1.70 Billion
P&H Tech Co. Ltd. KQ:239890	Korea	₩12.49 Billion
Hotel Royal Chihpen TWO:5704	Taiwan	NT$129.10 Million
Pusan Cast Iron Co., Ltd. KO:005030	Korea	₩212.67 Billion
Pudjiadi & Sons Tbk JK:PNSE	Indonesia	Rp155.87 Billion
Hakers Enterprise Co Ltd TWO:4432	Taiwan	NT$393.18 Million

Liability Composition Analysis (2014–2025)

This chart breaks down Medicenna Therapeutics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see how much is Medicenna Therapeutics Corp worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.68	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	2.20	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.10	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.52	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Medicenna Therapeutics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Medicenna Therapeutics Corp (2014–2025)

The table below shows the annual total liabilities of Medicenna Therapeutics Corp from 2014 to 2025.

Year	Total Liabilities	Change
2025-03-31	CA$9.29 Million ≈ $6.72 Million	-33.39%
2024-03-31	CA$13.94 Million ≈ $10.09 Million	+100.33%
2023-03-31	CA$6.96 Million ≈ $5.03 Million	+165.55%
2022-03-31	CA$2.62 Million ≈ $1.90 Million	-36.18%
2021-03-31	CA$4.11 Million ≈ $2.97 Million	+122.34%
2020-03-31	CA$1.85 Million ≈ $1.34 Million	-28.15%
2019-03-31	CA$2.57 Million ≈ $1.86 Million	+16.18%
2018-03-31	CA$2.21 Million ≈ $1.60 Million	-71.73%
2017-03-31	CA$7.83 Million ≈ $5.66 Million	+122.97%
2016-03-31	CA$3.51 Million ≈ $2.54 Million	+1102.65%
2015-03-31	CA$291.87K ≈ $211.13K	-64.83%
2014-03-31	CA$829.89K ≈ $600.33K	--

About Medicenna Therapeutics Corp

TO:MDNA Canada Biotechnology

Market Cap

$25.95 Million

CA$35.87 Million CAD

Market Cap Rank

#24294 Global

#927 in Canada

Share Price

CA$0.43

Change (1 day)

+3.61%

52-Week Range

CA$0.41 - CA$1.64

All Time High

CA$7.00